Kineret To Be Promoted To Rheumatologists By 35-Rep NPS Force
This article was originally published in The Pink Sheet Daily
Executive Summary
NPS expects the deal will pave the way for the possible 2005 launch of its osteoporosis agent Preos. Kineret sales have dropped since Amgen stopped promoting it in 2003.